Aurisco Pharmaceutical Co Ltd
SSE:605116
Aurisco Pharmaceutical Co Ltd
Cash from Financing Activities
Aurisco Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Aurisco Pharmaceutical Co Ltd
SSE:605116
|
Cash from Financing Activities
-¥14.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Cash from Financing Activities
-¥2.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
-5%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Financing Activities
-¥818.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Financing Activities
-¥789.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Financing Activities
-¥1.8B
|
CAGR 3-Years
-124%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-36%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Financing Activities
-¥2.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-25%
|
See Also
What is Aurisco Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-14.9m
CNY
Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -14.9m CNY.
What is Aurisco Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
72%
Over the last year, the Cash from Financing Activities growth was 72%.